Skip to main content
. Author manuscript; available in PMC: 2014 Oct 23.
Published in final edited form as: Mol Pharm. 2011 Apr 22;8(3):788–798. doi: 10.1021/mp100393j

Figure 8.

Figure 8

Transfection efficiencies of TAT peptide derivative/DNA complexes in A549 cells. (A) TAT/DNA and TAT-PEG/DNA complexes at an N/P ratio of 30 with different concentrations of calcium chloride (B) TAT/DNA complexes at different N/P ratios (C) TAT-PEG/DNA complexes at different N/P ratios. L= Lipofectamine.